2-Bromo-4-chloropyridine-3-carbaldehyde
正在补全数据,稍后刷新页面可查看最新内容
1289197-78-9O=Cc1c(Cl)ccnc1BrKCOAVFRTHTWKDO-UHFFFAOYSA-N1289197-78-9安全信息仅供参考,不能替代供应商安全技术说明书(SDS)、适用法规与专业评估。
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P264+P265, P270, P280, P301+P316, P305+P351+P338, P321, P330, P337+P317, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 41 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
生产方法一般步骤:在-70℃下,向2-溴-4-氯吡啶(1.6g,8.0mmol)的无水四氢呋喃(40mL)溶液中缓慢加入二异丙基氨基锂溶液(5.0mL,10.0mmol,2.0M),历时5分钟,并在-70℃下继续搅拌1小时。随后,在3分钟内滴加无水N,N-二甲基甲酰胺(1.3g),并将反应混合物在相同温度下再搅拌30分钟。反应完成后,用饱和氯化铵溶液(30mL)淬灭反应,用乙酸乙酯(20mL×3)萃取。合并有机层,用无水硫酸镁干燥,过滤,减压浓缩。通过硅胶柱色谱法纯化残余物,以石油醚/乙酸乙酯(20:1)为洗脱剂,得到2-溴-4-氯吡啶-3-甲醛(114a),为黄色固体(900mg,收率48%)。1H NMR(500MHz,DMSO)δ10.21(s,1H),8.52(d,J = 5.5Hz,1H),7.79(d,J = 5.0Hz,1H)。参考文献:[1] Patent: US2013/116262, 2013, A1. Location in patent: Paragraph 0307[2] Patent: EP2773638, 2015, B1. Location in patent: Paragraph 0185[3] Patent: US2013/116246, 2013, A1. Location in patent: Paragraph 0246